Revenue
33.6 million USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 33596000 USD Source
Market value
$73.23M
18,872,597 shares as of 2026-11-02, at $3.88 a share (OM, IEX close on 2026-11-12) Primary-source evidence
Annual consolidated revenue for 2025: about USD 119.5M, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports. The previous period, 2024, was about USD 113.7M.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-21.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
33.6 million USD
2026 Q3 · USD
-36.52%
2026 Q3 · %
-10.4 million USD
2026 Q3 · USD
-10.5 million USD
2026 Q3 · USD
33942000 USD
96237000 USD
18873000 shares
5.97% · 1.06 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
122 million USD
2025-10-01 – 2026-09-30
-42.4 million USD
2025-10-01 – 2026-09-30
508 thousand USD
2025-10-01 – 2026-09-30
-42.9 million USD
2025-10-01 – 2026-09-30
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-04.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 113.69 million
–
Current period
USD 119.48 million
–
119476000 − 113689000 = 5787000 USD
113689000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source119476000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 128 million
–
Current period
−USD 81.7 million
–
-81700000 − -128000000 = 46300000 USD
-128000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-81700000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 116.3 million
–
Current period
−USD 46.33 million
–
-46327000 − -116303000 = 69976000 USD
-116303000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-46327000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 912,000
–
Current period
USD 798,000
–
798000 − 912000 = -114000 USD
912000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source798000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2018 2018-01-01 – 2018-12-31 | 2007000 | 48570000 Derived | -46563000 | 3217000 Derived | -49780000 | -48208000 Derived | Source
|
| 2019 2019-01-01 – 2019-12-31 | 15078000 | 85385000 Derived | -70307000 | -2008000 Derived | -68299000 | -73585000 Derived | Source
|
| 2020 2020-01-01 – 2020-12-31 | 49935000 | 167402000 Derived | -117467000 | 4025000 Derived | -121492000 | -108092000 Derived | Source
|
| 2021 2021-01-01 – 2021-12-31 | 102602000 | 233121000 Derived | -130519000 | 1381000 Derived | -131900000 | -133372000 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 115375000 | 276394000 Derived | -161019000 | 1981000 Derived | -163000000 | -154054000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 130376000 | 300146000 Derived | -169770000 | 3030000 Derived | -172800000 | -134813000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 113689000 | 227064000 Derived | -113375000 | 14625000 Derived | -128000000 | -117215000 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 119476000 | 186182000 Derived | -66706000 | 14994000 Derived | -81700000 | -47125000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Revenue | 2007000 |
|
| 2019 | Revenue | 15078000 |
|
| 2020 | Revenue | 49935000 |
|
| 2021 | Revenue | 102602000 |
|
| 2022 | Revenue | 115375000 |
|
| 2023 | Revenue | 130376000 |
|
| 2024 | Revenue | 113689000 |
|
| 2025 | Revenue | 119476000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Year over year | No prior comparable period |
|
| 2019 | Year over year | 651.3% |
|
| 2020 | Year over year | 231.2% |
|
| 2021 | Year over year | 105.5% |
|
| 2022 | Year over year | 12.4% |
|
| 2023 | Year over year | 13% |
|
| 2024 | Year over year | -12.8% |
|
| 2025 | Year over year | 5.1% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Operating margin | -2,320% |
|
| 2019 | Operating margin | -466.3% |
|
| 2020 | Operating margin | -235.2% |
|
| 2021 | Operating margin | -127.2% |
|
| 2022 | Operating margin | -139.6% |
|
| 2023 | Operating margin | -130.2% |
|
| 2024 | Operating margin | -99.7% |
|
| 2025 | Operating margin | -55.8% |
|
| 2018 | Net margin | -2,480.3% |
|
| 2019 | Net margin | -453% |
|
| 2020 | Net margin | -243.3% |
|
| 2021 | Net margin | -128.6% |
|
| 2022 | Net margin | -141.3% |
|
| 2023 | Net margin | -132.5% |
|
| 2024 | Net margin | -112.6% |
|
| 2025 | Net margin | -68.4% |
|
| 2018 | Free cash flow margin | -2,402% |
|
| 2019 | Free cash flow margin | -488% |
|
| 2020 | Free cash flow margin | -216.5% |
|
| 2021 | Free cash flow margin | -130% |
|
| 2022 | Free cash flow margin | -133.5% |
|
| 2023 | Free cash flow margin | -103.4% |
|
| 2024 | Free cash flow margin | -103.1% |
|
| 2025 | Free cash flow margin | -39.4% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Operating cash flow | -46442000 |
|
| 2019 | Operating cash flow | -70292000 |
|
| 2020 | Operating cash flow | -99015000 |
|
| 2021 | Operating cash flow | -130264000 |
|
| 2022 | Operating cash flow | -145729000 |
|
| 2023 | Operating cash flow | -131373000 |
|
| 2024 | Operating cash flow | -116303000 |
|
| 2025 | Operating cash flow | -46327000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Free cash flow | -48208000 |
|
| 2019 | Free cash flow | -73585000 |
|
| 2020 | Free cash flow | -108092000 |
|
| 2021 | Free cash flow | -133372000 |
|
| 2022 | Free cash flow | -154054000 |
|
| 2023 | Free cash flow | -134813000 |
|
| 2024 | Free cash flow | -117215000 |
|
| 2025 | Free cash flow | -47125000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Liabilities / assets | 31% |
|
| 2019 | Liabilities / assets | 57.8% |
|
| 2020 | Liabilities / assets | 18.6% |
|
| 2021 | Liabilities / assets | 19.3% |
|
| 2022 | Liabilities / assets | 38.5% |
|
| 2023 | Liabilities / assets | 60.8% |
|
| 2024 | Liabilities / assets | 90.3% |
|
| 2025 | Liabilities / assets | 52% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Current assets / current liabilities | 14.46× |
|
| 2019 | Current assets / current liabilities | 3.2× |
|
| 2020 | Current assets / current liabilities | 9.43× |
|
| 2021 | Current assets / current liabilities | 7.93× |
|
| 2022 | Current assets / current liabilities | 7.19× |
|
| 2023 | Current assets / current liabilities | 5.26× |
|
| 2024 | Current assets / current liabilities | 5.69× |
|
| 2025 | Current assets / current liabilities | 6.67× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2018 2018-01-01 – 2018-12-31 | −USD 49.78 million Exact valueExact value: -49780000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 46.44 million Exact valueExact value: -46442000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.77 million Exact valueExact value: 1766000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 48.21 million Calculation and evidence-46442000 − 1766000 USD Exact free cash flow: -48208000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2019-01-01 – 2019-12-31 | −USD 68.3 million Exact valueExact value: -68299000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 70.29 million Exact valueExact value: -70292000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.29 million Exact valueExact value: 3293000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 73.59 million Calculation and evidence-70292000 − 3293000 USD Exact free cash flow: -73585000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | −USD 121.49 million Exact valueExact value: -121492000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 99.02 million Exact valueExact value: -99015000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 9.08 million Exact valueExact value: 9077000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 108.09 million Calculation and evidence-99015000 − 9077000 USD Exact free cash flow: -108092000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 131.9 million Exact valueExact value: -131900000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 130.26 million Exact valueExact value: -130264000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.11 million Exact valueExact value: 3108000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 133.37 million Calculation and evidence-130264000 − 3108000 USD Exact free cash flow: -133372000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 163 million Exact valueExact value: -163000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 145.73 million Exact valueExact value: -145729000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 8.33 million Exact valueExact value: 8325000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 154.05 million Calculation and evidence-145729000 − 8325000 USD Exact free cash flow: -154054000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 172.8 million Exact valueExact value: -172800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 131.37 million Exact valueExact value: -131373000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.44 million Exact valueExact value: 3440000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 134.81 million Calculation and evidence-131373000 − 3440000 USD Exact free cash flow: -134813000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 128 million Exact valueExact value: -128000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 116.3 million Exact valueExact value: -116303000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 912,000 Exact valueExact value: 912000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 117.22 million Calculation and evidence-116303000 − 912000 USD Exact free cash flow: -117215000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 81.7 million Exact valueExact value: -81700000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 46.33 million Exact valueExact value: -46327000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 798,000 Exact valueExact value: 798000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 47.13 million Calculation and evidence-46327000 − 798000 USD Exact free cash flow: -47125000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
57 filings · 2,160 latest values · 2,160 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001484612, 1484612, OM, edgar:1484612
Also known as Home Dialysis Plus, Ltd., Outset Medical, Inc.